Nkarta, Inc. (NKTX)
3.25
-0.05
(-1.52%)
USD |
NASDAQ |
May 29, 16:00
3.24
-0.01
(-0.31%)
Pre-Market: 20:00
Nkarta Shareholders Equity (Quarterly) : 285.86M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 1.013B |
| Gilead Sciences, Inc. | 23.52B |
| Inovio Pharmaceuticals, Inc. | 6.068M |
| ADMA Biologics, Inc. | 390.32M |
| Zenas BioPharma, Inc. | 335.83M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 372.07M |
| Total Liabilities (Quarterly) | 86.21M |
| Debt to Equity Ratio | 0.2624 |
| Current Ratio | 12.96 |
| Net Debt Paydown Yield | 0.70% |